Zhan‐Cheng Zeng

1.2k citations
20 papers · 836 indexed · h-index 16
Topics
RNA modifications and cancer (8 papers)Cancer-related molecular mechanisms research (8 papers)RNA Research and Splicing (7 papers)
Partner nations
ChinaMacao

In The Last Decade

Zhan‐Cheng Zeng

19 papers receiving 831 citations

Peers

Zhan‐Cheng Zeng
Comparison fields: 5 of 60
  • Molecular Biology 711
  • Cancer Research 455
  • Epidemiology 111
  • Oncology 95
  • Immunology 66
Replace Masatoshi Aida with:
Masatoshi Aida Japan
Devin Bready United States
Jihène Klibi France
Yogesh Srivastava China
Kanako Kuniyoshi Japan
Hao-Ming Chang United States
Amy M. Skinner United States
Richard Hildreth United States
Frank McCaughan United Kingdom
Ling-Li Lin United States
Zhan‐Cheng Zeng relative to Masatoshi Aida Japan Masatoshi Aida's profile →
Citations per field
00.5×5.6×
Masatoshi Aida · 1×
Citations per year

Countries citing papers authored by Zhan‐Cheng Zeng

Since Specialization
Citations

This map shows the geographic impact of Zhan‐Cheng Zeng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zhan‐Cheng Zeng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zhan‐Cheng Zeng more than expected).

Fields of papers citing papers by Zhan‐Cheng Zeng

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zhan‐Cheng Zeng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zhan‐Cheng Zeng. The network helps show where Zhan‐Cheng Zeng may publish in the future.

Co-authorship network of co-authors of Zhan‐Cheng Zeng

This figure shows the co-authorship network connecting the top 25 collaborators of Zhan‐Cheng Zeng. A scholar is included among the top collaborators of Zhan‐Cheng Zeng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zhan‐Cheng Zeng. Zhan‐Cheng Zeng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 30
3 27
4 30
5 22
6 1
7 181
8 81
9 59
10 32
11 22
12 35
13 52
14 167
15 20
16 13
17 15
18 12
19 19
20 18

About Zhan‐Cheng Zeng

Zhan‐Cheng Zeng is a scholar working on Cancer Research, Energy Engineering and Power Technology and Molecular Biology, having authored 20 papers that have together received 836 indexed citations. Recurring topics across this work include RNA modifications and cancer (8 papers), Cancer-related molecular mechanisms research (8 papers) and RNA Research and Splicing (7 papers). The work is most often cited by research in Cancer Research (455 citations), Molecular Biology (711 citations) and Oncology (95 citations). Zhan‐Cheng Zeng has collaborated with scholars based in China and Macao. Frequent co-authors include Yujie Chen, Ke Fang, Wei Huang, Tian-Qi Chen, Wentao Wang, Xue‐Qun Luo, Qi Pan, Cai Han, Lin-Yu Sun and Yumeng Sun. Their work appears in journals such as Blood, Molecular Cell and Clinical Cancer Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026